Sun et al. Journal of Experimental & Clinical Cancer Research 2011, 30:82 http://www.jeccr.com/content/30/1/82 17. Nakamura T, Shima T, Saeki A, et al: Expression of indoleamine 2, 3- dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer. Cancer Sci 2007, 98:874-81. 18. Witkiewicz A, Williams TK, Cozzitorto J, et al: Expression of indoleamine 2,3-dioxygenase in metastatic pancreatic ductal adenocarcinoma recruits regulatory T cells to avoid immune detection. J Am Coll Surg 2008, 206:849-54, discussion 54-6. 19. Travers MT, Gow IF, Barber MC, et al: Indoleamine 2,3-dioxygenase activity and L-tryptophan transport in human breast cancer cells. Biochim Biophys Acta 2004, 1661:106-12. 20. Mansfield AS, Heikkila PS, Vaara AT, et al: Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer. BMC Cancer 2009, 15:231. 21. Sharma MD, Baban B, Chandler P, et al: Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J Clin Invest 2007, 117:2570-82. 22. Munn DH, Sharma MD, Hou D, et al: Expression of indoleamine 2,3- dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J Clin Invest 2004, 114:280-90. 23. Liu JT, Yue J, Ren XB, et al: [Measurement of CD4+CD25+ T cells in breast cancer patients and its significance]. Zhonghua Zhong Liu Za Zhi 2005, 27:423-5. 24. Larmonier N, Marron M, Zeng Y, et al: Tumor-derived CD4(+)CD25(+) regulatory T cell suppression of dendritic cell function involves TGF-beta and IL-10. Cancer Immunol Immunother 2007, 56:48-59. 25. Puccetti P, Grohmann U: IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation. Nat Rev Immunol 2007, 7:817-23. doi:10.1186/1756-9966-30-82 Cite this article as: Sun et al.: Upregulated expression of indoleamine 2, 3-dioxygenase in CHO cells induces apoptosis of competent T cells and increases proportion of Treg cells. Journal of Experimental & Clinical Cancer Research 2011 30:82. Page 10 of 10 Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color ﬁgure charges • Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar • Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit